Page 2 - கோகெண்ட் உயிர் அறிவியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கோகெண்ட் உயிர் அறிவியல் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கோகெண்ட் உயிர் அறிவியல் இன்க் Today - Breaking & Trending Today

BioSpace Movers & Shakers, April 9

BioSpace Movers & Shakers, April 9
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Stanford University , United States , San Francisco , Libbie Mansell , Lee Shapiro , David Rubin , Jamie Krause , Goldman Sachs , Penrose Therapeutx , Dinesh Kapur , Srikantan Nagarajan , Muzammil Mansuri , John Robinson , Richard Bryce , Pamela Tenaerts , Michael Spigarelli , Biren Amin , Natalie Dickson , Carefirst Bluecross Blueshield , Robert Dubois , Dan Leonard , Randall Stanicky , Andrew Finberg , Dominic Moreland , Mircea Ivan , Carrolee Barlow ,

BioSpace Movers & Shakers, April 9

Published: Apr 09, 2021
By Alex Keown
Atara Biotherapeutics – Amie Krause was named Senior Vice President and Chief People Officer at Atara Biotherapeutics. In this role, Krause will be tasked with building a company culture that “rewards” values through actions and results. Prior to her tenure with Atara, Krause held several HR leadership positions at Amgen, including her role as Global HR Lead, Organizational Effectiveness during which she served as the human resources lead for Amgen’s global commercial operations covering the Americas, Europe, Asia, and the Middle East.
PsyBio Therapeutics – Michael Spigarelli was named chief medical officer of Ohio-based PsyBio. Before PsyBio Therapeutics, Spigarelli served as CMOr for Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases. Prior to that, he served as Vice President of Medical Affairs for Immucor, Inc., a leading provider of transfus ....

Stanford University , United States , San Francisco , Libbie Mansell , Lee Shapiro , David Rubin , Jamie Krause , Goldman Sachs , Penrose Therapeutx , Dinesh Kapur , Srikantan Nagarajan , Muzammil Mansuri , John Robinson , Richard Bryce , Pamela Tenaerts , Michael Spigarelli , Biren Amin , Natalie Dickson , Carefirst Bluecross Blueshield , Robert Dubois , Dan Leonard , Randall Stanicky , Andrew Finberg , Dominic Moreland , Mircea Ivan , Carrolee Barlow ,

Cogent Biosciences Announces Creation of Cogent Research Team

Cogent Biosciences Announces Creation of Cogent Research Team
Names industry veteran John Robinson, PhD as Chief Scientific Officer
New Boulder-based team with exceptional track record of drug discovery and development focused on creating novel small molecule therapies for rare, genetically driven diseases
Strong year-end cash position of $242.2 million supports company goals into 2024, including three CGT9486 clinical trials on-track to start this year, beginning with ASM in 1H21
News provided by
Share this article
Share this article
BOULDER, Colo. and CAMBRIDGE, Mass., April 6, 2021 /PRNewswire/ Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the formation of the Cogent Research Team led by newly appointed Chief Scientific Officer, John Robinson, PhD. ....

United States , United Kingdom , Boulder Denver , John Robinson , Compensation Committee Of The Board Directors , Cogent Research Team , Cogent Biosciences Inc , Drug Administration , University Of Delaware , Indiana University Of Pennsylvania , Cogent Biosciences , Chief Scientific Officer , Cogent Board , Vice President , Array Biopharma , New Drug , Indiana University , Advanced Systemic Mastocytosis , Non Advanced Systemic Mastocytosis , Gastrointestinal Stromal Tumors , Cogent Bioscience , Compensation Committee , Nasdaq Listing Rule , Private Securities Litigation Reform Act , Annual Report , ஒன்றுபட்டது மாநிலங்களில் ,

Boston-area pharmaceutical company opens research office in Boulder – BizWest

BOULDER Cogent Biosciences Inc. (Nasdaq: COGT) hired former Array Biopharma research leader John Robinson as its chief scientific officer, and said it will house a team of researchers in Boulder.
In a statement, Cambridge, Massachusetts-based Cogent said it plans to initially hire eight researchers in a rented laboratory space in north Boulder but eventually plans to build its own dedicated facility to house up to 50 researchers.
Robinson will lead the new team from Boulder after spending time as a vice president with pharmaceutical giant Pfizer Inc. (NYSE: PFE), which he joined after it acquired Array Biopharma in an
Cogent is focused on genetically-driven diseases thought to be caused by a shared genetic mutation within a specific type of protein receptor. ....

United Kingdom , United States , John Robinson , Pfizer Inc , Cogent Biosciences Inc , Bizwest Media , Cogent Biosciences , Array Biopharma , Massachusetts Based Cogent , West Media , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , ஜான் ராபின்சன் , ஃபைசர் இன்க் , கோகெண்ட் உயிர் அறிவியல் இன்க் , கோகெண்ட் உயிர் அறிவியல் , மாசசூசெட்ஸ் அடிப்படையிலானது கோகெண்ட் , மேற்கு மீடியா ,

Cogent Biosciences Announces Creation of Cogent Research Team

Cogent Biosciences Announces Creation of Cogent Research Team
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Boulder Denver , Andrew Robbins , John Robinson , Compensation Committee Of The Board Directors , Cogent Research Team , Cogent Biosciences Inc , Drug Administration , University Of Delaware , Prnewswire Cogent Biosciences Inc , Indiana University Of Pennsylvania , Chief Scientific Officer , Cogent Biosciences , Chief Executive Officer , Cogent Bioscience Chief Scientific , Cogent Bioscience , Cogent Board , Vice President , Array Biopharma , New Drug , Indiana University , Advanced Systemic Mastocytosis , Non Advanced Systemic Mastocytosis , Gastrointestinal Stromal Tumors , Inducement Grants ,